Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
May be repeated depending on your condition
Tesamorelin Modified GHRH analog designed for enhanced stability. In research, reduces visceral adipose tissue while increasing GH and IGF-1
A Growth Peptide Stack With a Visceral Fat Focus Tesamorelin is a stabilized analog of GHRH (growth hormone-releasing hormone), FDA-approved as the branded medication Egrifta for HIV-associated lipodystrophy
Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Twitter summary: @LillyDiabetes launches Trulicity in the US first ready-to-use once-weekly GLP-1, available w/savings program for commercially insured On November 10, Eli Lilly and company announced that Trulicity (dulaglutide) is now available in the US, making it the first ready-to-use once weekly GLP-1 receptor agonist to reach the market (no mixing required)
US$ 22.07
US$ 21.77
US$ 24.69
US$ 27.24
US$ 24.41
US$ 28.29
